While Viking Therapeutics Inc has overperformed by 4.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VKTX rose by 357.05%, with highs and lows ranging from $99.41 to $11.21, whereas the simple moving average fell by -16.93% in the last 200 days.
On November 04, 2024, H.C. Wainwright Reiterated Viking Therapeutics Inc (NASDAQ: VKTX) to Buy. A report published by JP Morgan on September 11, 2024, Initiated its previous ‘Overweight’ rating for VKTX. Morgan Stanley also rated VKTX shares as ‘Overweight’, setting a target price of $105 on the company’s shares in an initiating report dated June 27, 2024. Raymond James May 16, 2024d the rating to Strong Buy on May 16, 2024, and set its price target from $115 to $116. Oppenheimer resumed its ‘Outperform’ rating for VKTX, as published in its report on March 26, 2024. Jefferies’s report from March 07, 2024 suggests a price prediction of $110 for VKTX shares, giving the stock a ‘Buy’ rating. Oppenheimer also rated the stock as ‘Outperform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Viking Therapeutics Inc (VKTX)
One of the most important indicators of Viking Therapeutics Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -15.50% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 36.47, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and VKTX is recording 4.24M average volume. On a monthly basis, the volatility of the stock is set at 8.61%, whereas on a weekly basis, it is put at 7.89%, with a loss of -15.00% over the past seven days. Furthermore, long-term investors anticipate a median target price of $112.85, showing growth from the present price of $51.51, which can serve as yet another indication of whether VKTX is worth investing in or should be passed over.
How Do You Analyze Viking Therapeutics Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 3.04%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 73.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
VKTX shares are owned by institutional investors to the tune of 73.83% at present.
